Foralumab

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsNCT06292923TLSAPhase 2Completed2026-09-17Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.